MolecuLight Announces Integration with Intellicure Electronic Health Record (EHR) for Seamless Data and Image Transfer

August 27, 2024 -

Pittsburgh, PA, USA – August 27th, 2024 – MolecuLight Corp., the global leader in fluorescence imaging technology for real-time detection of harmful bacteria and digital wound measurement, announced today that their flagship wound imaging device, MolecuLightDX, seamlessly integrates with the Intellicure EHR platform.

Wound Care Clinicians who

Pioneering Innovation from MolecuLight Earns Best Abstract at SAWC Spring 2024

June 4, 2024 -

Toronto, CANADA – June 4th, 2024 – MolecuLight Inc., the global leader in fluorescence imaging technology for real-time detection of harmful bacteria in wound care, is proud to announce a groundbreaking study led by Drs. Charles Andersen and Alisha Oropallo, titled Enhancing Wound Care: The Synergistic Potential

MolecuLight’s Pioneering Fluorescence Imaging Technology Showcased in Prestigious Burns Journal in Novel Study

May 30, 2024 -

Toronto, CANADA – May 30th, 2024 – MolecuLight Inc., the global leader in fluorescence imaging technology for real-time detection of harmful bacteria in wound care, celebrates the publication of a groundbreaking study in the prestigious Burns Journal. Titled “Bacterial Fluorescence Imaging as a Predictor

MolecuLight Featured in 11 Presentations and Posters at European Wound Management Association (EWMA) 2024 Annual Conference

May 2, 2024 -Wide-Spread Clinical Evidence using the MolecuLight Imaging Platform Reveals its Significant Global Adoption and Proven Utility in Wound Care

Toronto, CANADA and London, UK – (May 1, 2024) – MolecuLight Corp., the leader in point-of-care digital wound measurement and real-time bacterial detection through fluorescence imaging, announces that its MolecuLight wound imaging